268 related articles for article (PubMed ID: 31103461)
1. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
Heart Rhythm; 2020 Jan; 17(1):e220-e228. PubMed ID: 31103461
[TBL] [Abstract][Full Text] [Related]
2. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
Stiles MK; Fauchier L; Morillo CA; Wilkoff BL;
Europace; 2019 Sep; 21(9):1442-1443. PubMed ID: 31090914
[TBL] [Abstract][Full Text] [Related]
3. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
J Interv Card Electrophysiol; 2020 Oct; 59(1):135-144. PubMed ID: 31960345
[TBL] [Abstract][Full Text] [Related]
4. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
J Arrhythm; 2019 Jun; 35(3):485-493. PubMed ID: 31293697
[TBL] [Abstract][Full Text] [Related]
5. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; Mcguire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S;
Europace; 2016 Feb; 18(2):159-83. PubMed ID: 26585598
[No Abstract] [Full Text] [Related]
6. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Mark Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; McGuire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S
Heart Rhythm; 2016 Feb; 13(2):e50-86. PubMed ID: 26607062
[No Abstract] [Full Text] [Related]
7. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Developed in collaboration with and endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS).
; Shah MJ; Silka MJ; Silva JNA; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Bergen NHV; Wackel PL
JACC Clin Electrophysiol; 2021 Nov; 7(11):1437-1472. PubMed ID: 34794667
[TBL] [Abstract][Full Text] [Related]
8. Programming implantable cardioverter-defibrillator in primary prevention: Guideline concordance and outcomes.
Ananwattanasuk T; Tanawuttiwat T; Chokesuwattanaskul R; Lathkar-Pradhan S; Barham W; Oral H; Thakur RK; Jongnarangsin K
Heart Rhythm; 2020 Jul; 17(7):1101-1106. PubMed ID: 32058014
[TBL] [Abstract][Full Text] [Related]
9. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients.
Shah MJ; Silka MJ; Silva JNA; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Von Bergen NH; Wackel PL;
Cardiol Young; 2021 Nov; 31(11):1738-1769. PubMed ID: 34338183
[TBL] [Abstract][Full Text] [Related]
10. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; McGuire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S
J Arrhythm; 2016 Feb; 32(1):1-28. PubMed ID: 26949427
[No Abstract] [Full Text] [Related]
11. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients.
; Shah MJ; Silka MJ; Silva JNA; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Bergen NHV; Wackel PL
Heart Rhythm; 2021 Nov; 18(11):1888-1924. PubMed ID: 34363988
[TBL] [Abstract][Full Text] [Related]
12. The impact of supraventricular arrhythmias on the outcomes of guideline-compliant implantable cardioverter defibrillator programming.
Teerawongsakul P; Ananwattanasuk T; Chokesuwattanaskul R; Shah M; Lathkar-Pradhan S; Barham W; Oral H; Thakur RK; Jongnarangsin K; Tanawuttiwat T
J Cardiovasc Electrophysiol; 2024 Apr; 35(4):794-801. PubMed ID: 38384108
[TBL] [Abstract][Full Text] [Related]
13. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients.
; Shah MJ; Silka MJ; Avari Silva JN; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Von Bergen NH; Wackel PL;
Indian Pacing Electrophysiol J; 2021; 21(6):367-393. PubMed ID: 34333141
[TBL] [Abstract][Full Text] [Related]
14. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.
Probst V; Boveda S; Sadoul N; Marquié C; Chauvin M; Mondoly P; Gras D; Jacon P; Defaye P; Leclercq C; Anselme F
Arch Cardiovasc Dis; 2020 May; 113(5):359-366. PubMed ID: 32334981
[TBL] [Abstract][Full Text] [Related]
16. Programming of implantable cardioverter defibrillators for primary prevention: outcomes at centers with high vs. low concordance with guidelines.
Teerawongsakul P; Ananwattanasuk T; Chokesuwattanaskul R; Shah M; Lathkar-Pradhan S; Barham W; Oral H; Thakur RK; Jongnarangsin K; Tanawuttiwat T
J Interv Card Electrophysiol; 2023 Sep; 66(6):1359-1366. PubMed ID: 36422768
[TBL] [Abstract][Full Text] [Related]
17. Failure to Treat Life-Threatening Ventricular Tachyarrhythmias in Contemporary Implantable Cardioverter-Defibrillators: Implications for Strategic Programming.
Thøgersen AM; Larsen JM; Johansen JB; Abedin M; Swerdlow CD
Circ Arrhythm Electrophysiol; 2017 Sep; 10(9):e005305. PubMed ID: 28916511
[TBL] [Abstract][Full Text] [Related]
18. Long-term prognosis in patients with Brugada syndrome based on Class II indication for implantable cardioverter-defibrillator in the HRS/EHRA/APHRS Expert Consensus Statement: multicenter study in Japan.
Takagi M; Sekiguchi Y; Yokoyama Y; Aihara N; Hiraoka M; Aonuma K;
Heart Rhythm; 2014 Oct; 11(10):1716-20. PubMed ID: 24981871
[TBL] [Abstract][Full Text] [Related]
19. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
Kusumoto FM; Calkins H; Boehmer J; Buxton AE; Chung MK; Gold MR; Hohnloser SH; Indik J; Lee R; Mehra MR; Menon V; Page RL; Shen WK; Slotwiner DJ; Warner Stevenson L; Varosy PD; Welikovitch L
Heart Rhythm; 2014 Jul; 11(7):1271-303. PubMed ID: 24819194
[No Abstract] [Full Text] [Related]
20. Optimal Implantable Cardioverter Defibrillator Programming.
Shah BK
Cardiol Rev; 2017; 25(1):30-35. PubMed ID: 27922468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
